Alvin Lee

Singapore General Hospital, SingHealth

Papers

4

Total Citations

43

H-Index

3

About

Dr. Alvin Lee is a pioneering urologic surgeon and researcher whose work is reshaping the landscape of prostate cancer diagnostics and robotic surgery. His primary research focuses on advancing precision medicine through multiparametric MRI-ultrasound fusion biopsy, particularly using stereotactic robot-assisted transperineal platforms. Dr. Lee’s landmark 2020 study, with 23 citations, demonstrated that targeted biopsy using this robotic system yields superior prostate cancer detection rates compared to systematic biopsy, establishing a new standard for diagnostic accuracy. He further revolutionized clinical practice by proving that these robotic biopsies can be safely performed under local anaesthesia in an outpatient clinic setting, moving a traditionally invasive procedure out of the operating theatre. Beyond diagnostics, Dr. Lee contributes to the Asian Robot-Assisted Radical Cystectomy Consortium, where his work on predicting perioperative outcomes has garnered 6 citations. Most recently, he is at the forefront of surgical innovation, documenting the transition to the hinotori™ robotic system. With a career dedicated to minimizing invasiveness while maximizing diagnostic and therapeutic precision, Dr. Lee is a leading voice in the future of urologic oncology.

Research Focus

Key Achievements

3
H-Index
4
Papers
43
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Multiparametric MRI‐ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic‐assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy
23 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Singapore General Hospital, SingHealth

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago